CIK 0000921299
- Non-accelerated filer
- Smaller reporting company
KYNTRA BIO, INC.
Sign in to watch- Ticker
- KYNB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 770357827
- Phone
- +1 415-978-1200
- Business address
- 350 BAY STREET, SUITE 100 #6009, SAN FRANCISCO, CA, 94133
- Former names
- FIBROGEN INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-03-19 | KEARNS THOMAS F JR Director | Exercise or conversion · Stock Option (Right to Buy) | −6,000 | 0 | ||
| 2020-03-19 | Chung Christine SVP, China Operations | Exercise or conversion | +7,345 | $25.40 | $187K | 166,358 |
| 2020-03-19 | Chung Christine SVP, China Operations | Sale | −300 | $23.93 | $7K | 166,058 |
| 2020-03-19 | Chung Christine SVP, China Operations | Sale | −830 | $25.32 | $21K | 165,228 |
| 2020-03-19 | Chung Christine SVP, China Operations | Sale | −6,215 | $26.08 | $162K | 159,013 |
| 2020-03-19 | Chung Christine SVP, China Operations | Exercise or conversion · Stock Option (Right to Buy) | −7,345 | 34,719 | ||
| 2020-03-18 | Chung Christine SVP, China Operations | Exercise or conversion | +400 | $25.40 | $10K | 162,918 |
| 2020-03-18 | Chung Christine SVP, China Operations | Sale | −905 | $23.69 | $21K | 162,013 |
| 2020-03-18 | Chung Christine SVP, China Operations | Sale | −1,500 | $24.56 | $37K | 160,513 |
| 2020-03-18 | Chung Christine SVP, China Operations | Sale | −1,500 | $25.68 | $39K | 159,013 |
| 2020-03-18 | Chung Christine SVP, China Operations | Exercise or conversion · Stock Option (Right to Buy) | −400 | 42,064 | ||
| 2020-03-17 | Chung Christine SVP, China Operations | Grant or award | +40,000 | 162,518 | ||
| 2020-03-17 | Chung Christine SVP, China Operations | Grant or award · Stock Option (Right to Buy) | +66,250 | 66,250 | ||
| 2020-03-17 | Yu K Peony Chief Medical Officer | Grant or award | +45,000 | 211,541 | ||
| 2020-03-17 | Yu K Peony Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +75,000 | 75,000 | ||
| 2020-03-17 | Kouchakji Elias SVP, Clinical Dev, Drug Safety | Grant or award | +37,500 | 132,191 | ||
| 2020-03-17 | Kouchakji Elias SVP, Clinical Dev, Drug Safety | Grant or award · Stock Option (Right to Buy) | +62,500 | 62,500 | ||
| 2020-03-17 | Cotroneo Pat SVP, Finance and CFO | Grant or award | +40,000 | 276,466 | ||
| 2020-03-17 | Cotroneo Pat SVP, Finance and CFO | Grant or award · Stock Option (Right to Buy) | +66,250 | 66,250 | ||
| 2020-03-16 | Yu K Peony Chief Medical Officer | Exercise or conversion | +3,750 | $19.39 | $73K | 166,541 |
Page 22 of 33 · 651 trades